Nan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nan Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Brett Chapman
Centre for Comparative Genomics, Murdoch University, South Street, Murdoch, Perth, WA 6150, Australia
1 shared publication - Deyou Qiu
State Key Laboratory of Tree Genetics and Breeding, Research Institute of Forestry, Chinese Academy of Forestry, Beijing 100091, China
1 shared publication - Gabriel Keeble-Gagnère
Centre for Comparative Genomics, Murdoch University, WA 6150, Australia
1 shared publication - Matthew I. Bellgard
Research Office, Queensland University of Technology, Brisbane, QLD, Australia
1 shared publication - Paula Moolhuijzen
Centre for Crop Disease and Management, School of Molecular and Life Sciences, Curtin University, Bentley, Western Australia, Australia
1 shared publication - Qi Tang
College of Horticulture, Hunan Agricultural University, Changsha 410128, China
1 shared publication
Latest Publications
- Open Access
- 13 December 2011
- Published by Springer Nature in BMC Genomics
- Vol. 12 (1) , 600
De novo assembly of Euphorbia fischeriana root transcriptome identifies prostratin pathway related genes
Background: Euphorbia fischerianais an important medicinal plant found in Northeast China. The plant roots contain many medicinal compounds including 12-deoxyphorbol-13-acetate, commonly known as prostratin that is a phorbol ester from the tigliane diterpene series. Prostratin is a protein kinase C activator and is effective in the treatment of Human Immunodeficiency Virus (HIV) by acting as a latent HIV activator. Latent HIV is currently the biggest limitation for viral eradication. The aim of this study was to sequence, assemble and annotate theE. fischerianatranscriptome to better understand the potential biochemical pathways leading to the synthesis of prostratin and other related diterpene compounds.Results: In this study we conducted a high throughput RNA-seq approach to sequence the root transcriptome ofE. fischeriana. We assembled 18,180 transcripts, of these the majority encoded protein-coding genes and only 17 transcripts corresponded to known RNA genes. Interestingly, we identified 5,956 protein-coding transcripts with high similarity (> = 75%) toRicinus communis, a close relative toE. fischeriana. We also evaluated the conservation ofE. fischerianagenes against EST datasets from the Euphorbeacea family, which includedR. communis,Hevea brasiliensisandEuphorbia esula. We identified a core set of 1,145 gene clusters conserved in all four species and 1,487E. fischerianaparalogous genes. Furthermore, we screenedE. fischerianatranscripts against an in-house reference database for genes implicated in the biosynthesis of upstream precursors to prostratin. This identified 24 and 9 candidate transcripts involved in the terpenoid and diterpenoid biosyntehsis pathways, respectively. The majority of the candidate genes in these pathways presented relatively low expression levels except for 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase (HDS) and isopentenyl diphosphate/dimethylallyl diphosphate synthase (IDS), which are required for multiple downstream pathways including synthesis of casbene, a proposed precursor to prostratin.Conclusion: The resources generated in this study provide new insights into the upstream pathways to the synthesis of prostratin and will likely facilitate functional studies aiming to produce larger quantities of this compound for HIV research and/or treatment of patients.
- 13 December 2011
- Published by Springer Nature in BMC Genomics
- Vol. 12 (1) , 600
Open AccessDe novo assembly of Euphorbia fischeriana root transcriptome identifies prostratin pathway related genes
Background: Euphorbia fischerianais an important medicinal plant found in Northeast China. The plant roots contain many medicinal compounds including 12-deoxyphorbol-13-acetate, commonly known as prostratin that is a phorbol ester from the tigliane diterpene series. Prostratin is a protein kinase C activator and is effective in the treatment of Human Immunodeficiency Virus (HIV) by acting as a latent HIV activator. Latent HIV is currently the biggest limitation for viral eradication. The aim of this study was to sequence, assemble and annotate theE. fischerianatranscriptome to better understand the potential biochemical pathways leading to the synthesis of prostratin and other related diterpene compounds.Results: In this study we conducted a high throughput RNA-seq approach to sequence the root transcriptome ofE. fischeriana. We assembled 18,180 transcripts, of these the majority encoded protein-coding genes and only 17 transcripts corresponded to known RNA genes. Interestingly, we identified 5,956 protein-coding transcripts with high similarity (> = 75%) toRicinus communis, a close relative toE. fischeriana. We also evaluated the conservation ofE. fischerianagenes against EST datasets from the Euphorbeacea family, which includedR. communis,Hevea brasiliensisandEuphorbia esula. We identified a core set of 1,145 gene clusters conserved in all four species and 1,487E. fischerianaparalogous genes. Furthermore, we screenedE. fischerianatranscripts against an in-house reference database for genes implicated in the biosynthesis of upstream precursors to prostratin. This identified 24 and 9 candidate transcripts involved in the terpenoid and diterpenoid biosyntehsis pathways, respectively. The majority of the candidate genes in these pathways presented relatively low expression levels except for 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase (HDS) and isopentenyl diphosphate/dimethylallyl diphosphate synthase (IDS), which are required for multiple downstream pathways including synthesis of casbene, a proposed precursor to prostratin.Conclusion: The resources generated in this study provide new insights into the upstream pathways to the synthesis of prostratin and will likely facilitate functional studies aiming to produce larger quantities of this compound for HIV research and/or treatment of patients.